IP Library › Assignment 031296/0492
Patent Assignment
Reel/Frame 031296/0492

Release of Security Interest

Recorded: 2013-09-27 Pages: 11
Assignor
MIDCAP FUNDING III, LLC
Executed: 2013-09-20
Assignees
PRECISION DERMATOLOGY COMPANY, INC.
900 HIGHLAND CORPORATE DRIVE, CUMBERLAND, RHODE ISLAND, 02864
ONSET DERMATOLOGICS, LLC
900 HIGHLAND CORPORATE DRIVE, CUMBERLAND, RHODE ISLAND, 02864
PROSKIN, LLC
900 HIGHLAND CORPORATE DRIVE, CUMBERLAND, RHODE ISLAND, 02864
PRECISION MD, LLC
900 HIGHLAND CORPORATE DRIVE, CUMBERLAND, RHODE ISLAND, 02864
TP CREAM SUB, LLC
900 HIGHLAND CORPORATE DRIVE, CUMBERLAND, RHODE ISLAND, 02864
TP LOTION SUB, LLC
900 HIGHLAND CORPORATE DRIVE, CUMBERLAND, RHODE ISLAND, 02864
Covered Properties (36)
Modulation of Zinc Levels to Improve Tissue Properties
Non-Flammable Topical Anesthetic Liquid Aerosols
Topical Aerosol Foams
Compositions for Topical Enzymatic Debridement
Skin Treatment Educational Kit
Topical Delivery with a Carrier Fluid
Topical Pharmaceutical Foam Composition
Foamable Benzoyl Peroxide Compositions for Topical Administration
Foamable Microemulsion Compositions for Topical Administration
Emollient Foams for Treatment of Dermatoses
Stable Aerosol Topical Foams Comprising a Hypochlorite Salt
Emollient Foams for Treatment of Seborrheic Dermatitis
High Oil-Content Emollient Aerosol Foam Compositions
Aerosol Foams Comprising Clindamycin Phosphate
Modulation of Zinc Levels to Improve Tissue Properties
Patent: 8,975,295 →
Application: 10/692,191 →
Publication: US 2004/0157921
Stabilized Steroid Composition and Method for Its Preparation
Patent: 7,378,405 →
Application: 10/762,652 →
Publication: US 2004/0152682
Non-flammable topical anesthetic liquid aerosols
Application: 10/956,819 →
Publication: US 2005/0123484
Skin treatment educational kit
Application: 11/418,514 →
Publication: US 2007/0166273
Stabilized Steroid Composition and Method for Its Preparation
Patent: 7,981,877 →
Application: 11/432,742 →
Publication: US 2006/0205703
7-Dimethylamino-6-Demethyl-6-Deoxytetracycline Skin Treatment Kit
Application: 11/459,778 →
Publication: US 2007/0166274
Topical Delivery with a Carrier Fluid
Application: 11/464,100 →
Publication: US 2007/0036731
Topical Pharmaceutical Foam Composition
Application: 11/552,457 →
Publication: US 2007/0154402
Foamable Microemulsion Compositions for Topical Administration
Patent: 8,652,443 →
Application: 12/371,155 →
Publication: US 2009/0232743
Foamable Benzoyl Peroxide Compositions for Topical Administration
Application: 12/546,189 →
Publication: US 2010/0202978
Emollient Foams for Treatment of Dermatoses
Application: 12/713,379 →
Publication: US 2011/0212035
Stabilized Steroid Composition and Method for its Preparation
Patent: 8,546,364 →
Application: 12/840,487 →
Publication: US 2010/0286108
Stable Aerosol Topical Foams Comprising a Hypochlorite Salt
Application: 12/872,566 →
Publication: US 2011/0052506
Emollient Foams for Treatment of Seborrheic Dermatitis
Patent: 8,623,330 →
Application: 13/017,204 →
Publication: US 2011/0229417
High Oil-Content Emollient Aerosol Foam Compositions
Patent: 8,784,780 →
Application: 13/046,088 →
Publication: US 2011/0305643
Aerosol Foams Comprising Clindamycin Phosphate
Patent: 8,592,380 →
Application: 13/053,524 →
Publication: US 2011/0236321
Stabilized Steroid Composition and Method for Its Preparation
Patent: 8,389,502 →
Application: 13/155,493 →
Publication: US 2011/0237811
Method and System for Automatic Product Replenishment
Application: 13/249,960 →
Publication: US 2013/0085957
Tandem Hypochlorite-Barrier Repair Therapy for the Treatment of Eczema
Application: 13/313,468 →
Publication: US 2012/0148516
Topical Pharmaceutical Foam Composition
Application: 13/343,906 →
Publication: US 2012/0128598
Topical Delivery with a Carrier Fluid
Application: 13/409,608 →
Publication: US 2012/0189557
Stable Dermatological Aerosol Foams Utilizing Reactive Propellants
Application: 61/555,045 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest Apr 26, 2012
From: LAMINAR DIRECT CAPITAL, L.L.C. AS SUCCESSOR IN INTEREST TO LAMINAR DIRECT CAPITAL, L.P.
To: TRIAX PHARMACEUTICALS, LLC
Reel/Frame 028114/0337 →
Security Agreement May 18, 2012
From: PRECISION DERMATOLOGY, INC.; ONSET DERMATOLOGICS, LLC; PROSKIN LLC; PRECISION MD LLC
To: MIDCAP FUNDING III, LLC
Reel/Frame 028234/0424 →
Assignment of Assignor's Interest Aug 22, 2012
From: PATEL, PRAVIN M.
To: FERNDALE IP, INC.
Reel/Frame 028828/0674 →
Assignment of Assignor's Interest Aug 22, 2012
From: FERNDALE LABORATORIES, INC.
To: TRIAX PHARMACEUTICALS, LLC
Reel/Frame 028828/0984 →
Assignment of Assignor's Interest Aug 22, 2012
From: FERNDALE IP, INC.
To: TRIAX PHARMACEUTICALS, LLC
Reel/Frame 028828/0702 →
Assignment of Assignor's Interest Aug 22, 2012
From: TRIAX PHARMACEUTICALS, LLC
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 028828/0598 →
Assignment of Assignor's Interest Sep 28, 2012
From: REVANCE THERAPEUTICS, INC.
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 029043/0761 →
Release of Security Interest Sep 11, 2013
From: FERNDALE LABORATORIES, INC.
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 031184/0126 →
Security Agreement Sep 20, 2013
From: PRECISION DERMATOLOGY, INC.
To: GCI CAPITAL MARKETS LLC
Reel/Frame 031249/0011 →
Corrective Assignment to Correct the Release of Secured Party Previously Recorded on Reel 013384 Frame 0126. Assignor(S) Hereby Confirms the Correction of Doc Date from 4-25-2012 to 9-9-2013. Oct 29, 2013
From: FERNDALE LABORATORIES, INC.
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 031509/0788 →
Release of Security Interest Jul 7, 2014
From: GCI CAPITAL MARKETS, LLC
To: PRECISION DERMATOLOGY, INC.
Reel/Frame 033280/0556 →
Security Interest May 20, 2015
From: ENCORE DERMATOLOGY, INC.
To: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Reel/Frame 035681/0733 →
Security Agreement Jul 6, 2015
From: ECR PHARMACEUTICALS CO., INC.; PRECISION DERMATOLOGY, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 036091/0257 →
Assignment of Assignor's Interest Aug 26, 2015
From: VALEANT PHARMACEUTICALS NORTH AMERICA LLC; PRECISION DERMATOLOGY, INC.; VALEANT PHARMACEUTICALS IRELAND; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.
To: ENCORE DERMATOLOGY, INC.
Reel/Frame 036428/0744 →
Security Interest Jul 19, 2017
From: PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043041/0864 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Intellectual Property Security Agreement Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Security Interest Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
Security Agreement Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
Security Agreement (First Lien) Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien) Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
U.S. Patent Security Agreement Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →